Cravath Guides Mylan In Up To $1B Deal For Pharma Biz
Cravath Swaine & Moore LLP steered Mylan N.V.'s acquisition of a branded and generic prescription business from Renaissance Acquisition Holdings LLC in a deal totaling as much as $1 billion, according...To view the full article, register now.
Already a subscriber? Click here to view full article